Highlighting the Top 20 scientists in two categories: cannabis analysis and cannabis research.
Cannabis researchers face numerous challenges – and not just in the lab
Training the cannabis scientists of tomorrow has never been more important
How are Canadians using medical cannabis?
Freeing the roads of THC-intoxicated drivers, one breathalyzer test at a time
The message is clear: we need more evidence. But are randomized, controlled trials the answer?
Does CBD really counteract the neuropsychiatric risks of THC?
Could synthetic biology facilitate a microbial revolution... and do away with grow rooms for good?
Heavy metal contaminants pose a risk to health – the cannabis industry must react accordingly.
Sitting Down With... Mike Barnes, Chief Medical Officer, Lyphe Group, London, UK and Chairman, Maple Tree Consultancy, Chester, UK.
A dose-escalation study aims to quantify the value of CBD in children with epileptic encephalopathy.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.